{"id":"W7095094585","doi":"","title":"Site Group * of Cancer Care Ontario’s","year":2013,"lang":"en","type":"article","venue":"","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Alemtuzumab; Hematology; Chronic lymphocytic leukemia; Cancer; Guideline; Radiation therapy; Disease; Leukemia","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001419698,0.0003060522,0.0003387052,0.0007883399,0.002962519,0.002143395,0.001225745,0.002084818,0.1366057],"category_scores_gemma":[0.009534551,0.0003367303,0.0005044266,0.002204238,0.00079567,0.0008228907,0.000957636,0.0008936176,0.01181146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02933468,"about_ca_system_score_gemma":0.08987407,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8634761,"about_ca_topic_score_gemma":0.9581993,"domain_scores_codex":[0.9978594,0.000223581,0.0001511692,0.0002547778,0.001032999,0.0004780201],"domain_scores_gemma":[0.9854338,0.0009429398,0.0009483463,0.0004364867,0.008201717,0.004036632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006922273,0.00001842417,0.01150713,0.000215312,0.00001310403,0.0001080598,0.0001844013,0.00004206017,0.0001383882,0.00177579,0.9502482,0.03567983],"study_design_scores_gemma":[0.0000984365,0.00003035895,0.02460523,0.0003027019,0.00002044416,0.0001078041,0.000332761,0.00005530493,0.00008260128,0.00030151,0.9740491,0.00001378681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01877243,0.005993836,0.0006000221,0.1554623,0.0028653,0.001499289,0.0409787,0.0002852951,0.7735429],"genre_scores_gemma":[0.1390325,0.0083329,0.003548178,0.08683363,0.001343873,0.001383688,0.02601389,0.0002576212,0.7332537],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.8634761,"threshold_uncertainty_score":0.4569917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01499413010670671,"score_gpt":0.3029350737875081,"score_spread":0.2879409436808014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}